Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miaoyan Wei
A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
High Expression of CXCR4 May Predict Poor Survival in Resected Pancreatic Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology
Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Infiltrating Immune Cells and Gene Mutations in Pancreatic Ductal Adenocarcinoma
British Journal of Surgery
Surgery
Sonic Hedgehog and Gli1 Expression Predict Outcome in Resected Pancreatic Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Nationwide Trends in Incidence, Treatment and Survival of Pancreatic Ductal Adenocarcinoma
European Journal of Cancer
Cancer Research
Oncology
A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
Journal of Cancer
Oncology
The Impact of a History of Cancer on Pancreatic Ductal Adenocarcinoma Survival
United European Gastroenterology Journal
Oncology
Gastroenterology